Market Overview:
The global cellular reprogramming tools market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for regenerative medicine and drug development applications. In addition, the increasing focus on stem cell research is also contributing to the growth of this market. The global cellular reprogramming tools market can be segmented on the basis of type into adult stem cells, human embryonic stem cells, induced pluripotent stem cells, and other types. The adult stem cells segment is expected to account for a major share of the global cellular reprogramming tools market in 2018. This segment is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The human embryonic stem cells segment is projected to grow at a high rate during the forecast period owingto its ability tomaintain pluripotency and generate all somatic cell types in vitro .
Product Definition:
Cellular Reprogramming Tools are used to reprogram cells, typically by altering the expression of genes. This can be used to change the phenotype of a cell, or to convert one type of cell into another.
Adult Stem Cells:
The global adult stem cells market is expected to witness significant growth over the forecast period. The factors that propel the growth of this market are increasing incidences of age-related disorders, growing research and development in cellular reprogramming tools, rising demand for cell therapy products from various end-user segments such as regenerative medicine and drug discovery & development among others.
Adult stem cells have a unique ability to regenerate tissues and organs by changing their functional characteristics through differentiation induction.
Human Embryonic Stem Cells:
Human embryonic stem cells are pluripotent cells that can differentiate into all the cell types in the human body. These have been extracted from blastocysts, which is when they are at an early stage of development and can be reprogrammed to form any type of tissue. They possess great regenerative potential and have been proven to be capable of healing many degenerative diseases including Parkinson’s, Alzheimer’s, & spinal cord injuries along with other chronic conditions.
Application Insights:
Regenerative medicine segment held the largest share of regenerative medicine in 2016. Cellular reprogramming techniques have been proved to be a great solution for clinical application in stem cell therapies and regenerative medicines. The growing number of clinical trials supporting the use of adult stem cells and induced pluripotent stem cells (iPSCs) for treating several life-threatening conditions, such as diabetes, is expected to boost revenue generation in this segment over the forecast period.
Cellular reprogramming has proven itself as an efficient method for generating patient-specific induced pluripotent stromal cells (iPSCs). These iPSCs can be used not only for research but also as a potential therapy option for various diseases including cardiovascular disorders, Type 1 diabetes mellitus and Parkinson¢â‚¬â„¢s disease.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in research activities and development of advanced cellular therapies. Moreover, increasing cases of chronic diseases are expected to boost the demand for cell therapy products, thereby driving regional growth. The U.S.-based companies have been making significant contributions by developing novel technologies and strategic collaborations with other organizations for commercialization of their products. For instance, Novocure-Stem Cell Therapy received CE Mark for its product lines that can be used for treating neurodegenerative diseases such as Parkinson’s disease and Alzheimer's disease using adult stem cells (ASCs).
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising investments by private firms as well as public agencies in countries such as Japan, China, Singapore and India aimed at promoting medical tourism due to affordable treatments available here compared with those offered by international hospitals & clinics.
Growth Factors:
- Increasing demand for regenerative medicine
- Rising prevalence of chronic diseases
- Technological advancements in cellular reprogramming tools
- Growing number of research and development activities in the field of regenerative medicine
- Increasing funding for research and development in the field of regenerative medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
Cellular Reprogramming Tools Market Research Report
By Type
Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Other
By Application
Drug Development, Regenerative Medicine, Toxicity Test, Academic Research, Other
By Companies
Celgene, BIOTIME, Human Longevity, Advanced Cell Technology, Mesoblast, STEMCELL Technologies, Osiris Therapeutics, Cynata, Astellas Pharma, FUJIFILM Holdings, EVOTEC, Japan Tissue Engineering
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
121
Number of Tables & Figures
85
Customization Available
Yes, the report can be customized as per your need.
Global Cellular Reprogramming Tools Market Report Segments:
The global Cellular Reprogramming Tools market is segmented on the basis of:
Types
Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Development, Regenerative Medicine, Toxicity Test, Academic Research, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Celgene
- BIOTIME
- Human Longevity
- Advanced Cell Technology
- Mesoblast
- STEMCELL Technologies
- Osiris Therapeutics
- Cynata
- Astellas Pharma
- FUJIFILM Holdings
- EVOTEC
- Japan Tissue Engineering
Highlights of The Cellular Reprogramming Tools Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Adult Stem Cells
- Human Embryonic Stem Cells
- Induced Pluripotent Stem Cells
- Other
- By Application:
- Drug Development
- Regenerative Medicine
- Toxicity Test
- Academic Research
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cellular Reprogramming Tools Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cellular reprogramming tools are a type of laboratory tool used to change the genetic makeup of cells.
Some of the major players in the cellular reprogramming tools market are Celgene, BIOTIME, Human Longevity, Advanced Cell Technology, Mesoblast, STEMCELL Technologies, Osiris Therapeutics, Cynata, Astellas Pharma, FUJIFILM Holdings, EVOTEC, Japan Tissue Engineering.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cellular Reprogramming Tools Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cellular Reprogramming Tools Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cellular Reprogramming Tools Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cellular Reprogramming Tools Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cellular Reprogramming Tools Market Size & Forecast, 2018-2028
4.5.1 Cellular Reprogramming Tools Market Size and Y-o-Y Growth
4.5.2 Cellular Reprogramming Tools Market Absolute $ Opportunity
Chapter 5 Global Cellular Reprogramming Tools Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cellular Reprogramming Tools Market Size Forecast by Type
5.2.1 Adult Stem Cells
5.2.2 Human Embryonic Stem Cells
5.2.3 Induced Pluripotent Stem Cells
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cellular Reprogramming Tools Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cellular Reprogramming Tools Market Size Forecast by Applications
6.2.1 Drug Development
6.2.2 Regenerative Medicine
6.2.3 Toxicity Test
6.2.4 Academic Research
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cellular Reprogramming Tools Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cellular Reprogramming Tools Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cellular Reprogramming Tools Analysis and Forecast
9.1 Introduction
9.2 North America Cellular Reprogramming Tools Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cellular Reprogramming Tools Market Size Forecast by Type
9.6.1 Adult Stem Cells
9.6.2 Human Embryonic Stem Cells
9.6.3 Induced Pluripotent Stem Cells
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cellular Reprogramming Tools Market Size Forecast by Applications
9.10.1 Drug Development
9.10.2 Regenerative Medicine
9.10.3 Toxicity Test
9.10.4 Academic Research
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cellular Reprogramming Tools Analysis and Forecast
10.1 Introduction
10.2 Europe Cellular Reprogramming Tools Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cellular Reprogramming Tools Market Size Forecast by Type
10.6.1 Adult Stem Cells
10.6.2 Human Embryonic Stem Cells
10.6.3 Induced Pluripotent Stem Cells
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cellular Reprogramming Tools Market Size Forecast by Applications
10.10.1 Drug Development
10.10.2 Regenerative Medicine
10.10.3 Toxicity Test
10.10.4 Academic Research
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cellular Reprogramming Tools Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cellular Reprogramming Tools Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cellular Reprogramming Tools Market Size Forecast by Type
11.6.1 Adult Stem Cells
11.6.2 Human Embryonic Stem Cells
11.6.3 Induced Pluripotent Stem Cells
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cellular Reprogramming Tools Market Size Forecast by Applications
11.10.1 Drug Development
11.10.2 Regenerative Medicine
11.10.3 Toxicity Test
11.10.4 Academic Research
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cellular Reprogramming Tools Analysis and Forecast
12.1 Introduction
12.2 Latin America Cellular Reprogramming Tools Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cellular Reprogramming Tools Market Size Forecast by Type
12.6.1 Adult Stem Cells
12.6.2 Human Embryonic Stem Cells
12.6.3 Induced Pluripotent Stem Cells
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cellular Reprogramming Tools Market Size Forecast by Applications
12.10.1 Drug Development
12.10.2 Regenerative Medicine
12.10.3 Toxicity Test
12.10.4 Academic Research
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cellular Reprogramming Tools Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cellular Reprogramming Tools Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cellular Reprogramming Tools Market Size Forecast by Type
13.6.1 Adult Stem Cells
13.6.2 Human Embryonic Stem Cells
13.6.3 Induced Pluripotent Stem Cells
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cellular Reprogramming Tools Market Size Forecast by Applications
13.10.1 Drug Development
13.10.2 Regenerative Medicine
13.10.3 Toxicity Test
13.10.4 Academic Research
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cellular Reprogramming Tools Market: Competitive Dashboard
14.2 Global Cellular Reprogramming Tools Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Celgene
14.3.2 BIOTIME
14.3.3 Human Longevity
14.3.4 Advanced Cell Technology
14.3.5 Mesoblast
14.3.6 STEMCELL Technologies
14.3.7 Osiris Therapeutics
14.3.8 Cynata
14.3.9 Astellas Pharma
14.3.10 FUJIFILM Holdings
14.3.11 EVOTEC
14.3.12 Japan Tissue Engineering
